Oncology & Cancer

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.

Immunology

Could cytotoxic T-cells be a key to longevity?

Scientists from the RIKEN Center for Integrative Medical Science (IMS) and Keio University School of Medicine in Japan have used single-cell RNA analysis to find that supercentenarians—meaning people over the age of 110—have ...

Immunology

Vaccine investigators use bacterium's own protein against it

A team of Agricultural Research Service (ARS) and university scientists is investigating a new "ingredient" for use in vaccinating cattle against Johne's disease, a chronic wasting affliction that costs the U.S. dairy industry ...

Cardiology

Atherosclerosis: Induced cell death destabilizes plaques

Many chronic disorders arise from misdirected immune responses. A Ludwig-Maximilians-Universitaet (LMU) team led by Oliver Söhnlein now shows that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death ...

page 7 from 15